| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | PANORAMA RESEARCH INCORPORATED | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43DE033577 | Novel therapy to prevent alveolar bone loss in severe periodontitis | 000 | 1 | NIH | 10/17/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $304,019 ) |
| | 2024 | 2024 | PANORAMA RESEARCH INCORPORATED | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43DE033577 | Novel therapy to prevent alveolar bone loss in severe periodontitis | 000 | 1 | NIH | 8/14/2024 | $304,019 |
|
| Issue Date FY: 2023 ( Subtotal = $575,754 ) |
| | 2023 | 2023 | PANORAMA RESEARCH INCORPORATED | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43AR082791 | Novel therapy for arthrofibrosis | 000 | 1 | NIH | 9/26/2023 | $275,765 |
| | 2023 | 2023 | PANORAMA RESEARCH INCORPORATED | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43NS134421 | Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia | 000 | 1 | NIH | 8/11/2023 | $299,989 |
| | 2023 | 2019 | PANORAMA RESEARCH INCORPORATED | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44AI120433 | Monoclonal antibody for autoimmune disease | 000 | 3 | NIH | 5/15/2023 | $0 |
| | 2023 | 2019 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44AI120433 | Monoclonal antibody for autoimmune disease | 001 | 3 | NIH | 7/7/2023 | $0 |
| | 2023 | 2018 | PANORAMA RESEARCH INCORPORATED | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44AG047709 | Novel NMDA-targeted Therapy for Alzheimer's Disease | 001 | 3 | NIH | 8/18/2023 | $0 |
| | 2023 | 2018 | PANORAMA RESEARCH INCORPORATED | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44AG047709 | Novel NMDA-targeted Therapy for Alzheimer's Disease | 000 | 3 | NIH | 5/15/2023 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2019 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44AI120433 | Monoclonal antibody for autoimmune disease | 000 | 3 | NIH | 2/17/2021 | $0 |
| | 2021 | 2018 | PANORAMA RESEARCH INCORPORATED | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44AG047709 | Novel NMDA-targeted Therapy for Alzheimer's Disease | 000 | 3 | NIH | 7/21/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = -$20,217 ) |
| | 2020 | 2018 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R21CA201940 | Stem Cell-Adrenomedullin Therapy for Cancer Linked Lymphedema | 000 | 3 | NIH | 8/24/2020 | $0 |
| | 2020 | 2018 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44HL126375 | Rational antibody therapy for IPF | 000 | 3 | NIH | 4/6/2020 | $0 |
| | 2020 | 2018 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44AG047709 | Novel NMDA-targeted Therapy for Alzheimer's Disease | 000 | 3 | NIH | 6/18/2020 | $0 |
| | 2020 | 2014 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43DK102231 | Novel therapy for disorders of iron overload | 000 | 1 | NIH | 10/1/2019 | -$3,309 |
| | 2020 | 2014 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43DK099006 | Novel Targeted Cytokine for Chronic Kidney Disease | 000 | 1 | NIH | 10/1/2019 | -$2,066 |
| | 2020 | 2014 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43CA180330 | Monobody therapy for gynecologic cancers | 000 | 1 | NIH | 10/1/2019 | -$10,588 |
| | 2020 | 2014 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43NS087730 | Tunable Frataxin Replacement Therapy | 000 | 1 | NIH | 10/1/2019 | -$3,605 |
| | 2020 | 2014 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43AG047709 | Novel NMDA-targeted Therapy for Alzheimer's Disease | 000 | 1 | NIH | 10/1/2019 | -$649 |
|
| Issue Date FY: 2019 ( Subtotal = $824,301 ) |
| | 2019 | 2019 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44AI120433 | Monoclonal antibody for autoimmune disease | 000 | 3 | NIH | 2/1/2019 | $905,412 |
| | 2019 | 2016 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43AG055376 | Novel therapy for erosive bone disease | 000 | 1 | NIH | 3/1/2019 | -$52,166 |
| | 2019 | 2016 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43HL132692 | Hepcidin Antagonist Therapy for Anemia of Chronic Disease | 000 | 1 | NIH | 1/23/2019 | -$8,200 |
| | 2019 | 2016 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44AI109982 | Antibody-Membrane Switch (AMS) technology for optimized antibody engineering | 000 | 3 | NIH | 11/26/2018 | $0 |
| | 2019 | 2016 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43AG054406 | Novel Aminoadamantane Nitrates for the Treatment of Neurological Diseases | 000 | 1 | NIH | 2/4/2019 | -$16,867 |
| | 2019 | 2016 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43DK111277 | Novel Anti-inflammmatory Antibody Therapy for Inflammatory Bowel Disease | 000 | 1 | NIH | 1/28/2019 | -$3,878 |
|
| Issue Date FY: 2018 ( Subtotal = $2,157,760 ) |
| | 2018 | 2018 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R21CA201940 | Stem Cell-Adrenomedullin Therapy for Cancer Linked Lymphedema | 000 | 3 | NIH | 2/1/2018 | $94,683 |
| | 2018 | 2018 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44HL126375 | Rational antibody therapy for IPF | 000 | 3 | NIH | 3/23/2018 | $758,362 |
| | 2018 | 2018 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44AG047709 | Novel NMDA-targeted Therapy for Alzheimer's Disease | 001 | 3 | NIH | 8/7/2018 | $710,940 |
| | 2018 | 2018 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44AI120433 | Monoclonal antibody for autoimmune disease | 000 | 2 | NIH | 2/6/2018 | $592,822 |
| | 2018 | 2018 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R21CA201940 | Stem Cell-Adrenomedullin Therapy for Cancer Linked Lymphedema | 001 | 3 | NIH | 9/17/2018 | $14,355 |
| | 2018 | 2017 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44AG047709 | Novel NMDA-targeted Therapy for Alzheimer's Disease | 000 | 2 | NIH | 8/4/2018 | $0 |
| | 2018 | 2015 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43DK108416 | Novel NMDA Receptor Antagonists for Beta Cell Rescue | 000 | 1 | NIH | 1/12/2018 | $0 |
| | 2018 | 2015 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43AI120433 | Monoclonal antibody for autoimmune disease | 000 | 1 | NIH | 12/7/2017 | -$5,648 |
| | 2018 | 2015 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43AR068811 | Novel therapy for Netherton syndrome | 000 | 1 | NIH | 1/10/2018 | $0 |
| | 2018 | 2014 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43DK099006 | Novel Targeted Cytokine for Chronic Kidney Disease | 000 | 1 | NIH | 1/4/2018 | -$7,754 |
|
| Issue Date FY: 2017 ( Subtotal = $1,611,446 ) (Continued on the next page) |
| | 2017 | 2017 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44AG047709 | Novel NMDA-targeted Therapy for Alzheimer's Disease | 000 | 2 | NIH | 9/9/2017 | $788,076 |
| | 2017 | 2017 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R44HL126375 | Rational antibody therapy for IPF | 000 | 2 | NIH | 6/19/2017 | $735,251 |
| | 2017 | 2016 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R21CA201940 | Stem Cell-Adrenomedullin Therapy for Cancer Linked Lymphedema | 003 | 2 | NIH | 8/28/2017 | $17,021 |
| | 2017 | 2016 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R21CA201940 | Stem Cell-Adrenomedullin Therapy for Cancer Linked Lymphedema | 001 | 2 | NIH | 6/29/2017 | $96,890 |
| | 2017 | 2015 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43DK103400 | Neutralization of Fibrosis-promoting Marinobufagenin for Diabetic Nephropathy | 000 | 1 | NIH | 8/25/2017 | $0 |
| | 2017 | 2015 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43HL126375 | Rational antibody therapy for IPF | 000 | 1 | NIH | 4/11/2017 | -$1,621 |
| | 2017 | 2014 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43HD079238 | Point-of-care immunoassay panel for cardiotonic steroids | 000 | 1 | NIH | 8/22/2017 | -$14,440 |
| | 2017 | 2014 | PANORAMA RESEARCH | 1230 BORDEAUX DR | SUNNYVALE | CA | 94089-1202 | SANTA CLARA | USA | R43GM109620 | Novel Hybrid Growth Factor for Immune Reconstitution in Sepsis | 000 | 1 | NIH | 8/7/2017 | $0 |
|
